Docality.com Logo
 
Dr. Alexander  Gomelsky  Md image

Dr. Alexander Gomelsky Md

1501 Kings Hwy Department Of Urology
Shreveport LA 71103
318 132-2750
Medical School: University Of Maryland School Of Medicine - 1997
Accepts Medicare: Yes
Participates In eRX: No
Participates In PQRS: Yes
Participates In EHR: No
License #: 15563R
NPI: 1730105818
Taxonomy Codes:
208800000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Alexander Gomelsky is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:51715 Description:Endoscopic injection/implant Average Price:$3,267.00 Average Price Allowed
By Medicare:
$188.96
HCPCS Code:57288 Description:Repair bladder defect Average Price:$2,663.00 Average Price Allowed
By Medicare:
$582.22
HCPCS Code:52332 Description:Cystoscopy and treatment Average Price:$1,683.60 Average Price Allowed
By Medicare:
$143.30
HCPCS Code:51729 Description:Cystometrogram w/vp&up Average Price:$980.00 Average Price Allowed
By Medicare:
$119.85
HCPCS Code:51784 Description:Anal/urinary muscle study Average Price:$830.27 Average Price Allowed
By Medicare:
$36.44
HCPCS Code:51741 Description:Electro-uroflowmetry first Average Price:$534.83 Average Price Allowed
By Medicare:
$8.74
HCPCS Code:52000 Description:Cystoscopy Average Price:$615.00 Average Price Allowed
By Medicare:
$115.05
HCPCS Code:51600 Description:Injection for bladder x-ray Average Price:$513.00 Average Price Allowed
By Medicare:
$23.84
HCPCS Code:51705 Description:Change of bladder tube Average Price:$513.00 Average Price Allowed
By Medicare:
$46.96
HCPCS Code:51702 Description:Insert temp bladder cath Average Price:$479.00 Average Price Allowed
By Medicare:
$28.15
HCPCS Code:51797 Description:Intraabdominal pressure test Average Price:$487.00 Average Price Allowed
By Medicare:
$38.26
HCPCS Code:51700 Description:Irrigation of bladder Average Price:$274.00 Average Price Allowed
By Medicare:
$42.01
HCPCS Code:51701 Description:Insert bladder catheter Average Price:$246.00 Average Price Allowed
By Medicare:
$25.79
HCPCS Code:51798 Description:Us urine capacity measure Average Price:$196.00 Average Price Allowed
By Medicare:
$16.80
HCPCS Code:99204 Description:Office/outpatient visit new Average Price:$273.00 Average Price Allowed
By Medicare:
$119.28
HCPCS Code:57160 Description:Insert pessary/other device Average Price:$194.00 Average Price Allowed
By Medicare:
$44.73
HCPCS Code:74455 Description:X-ray urethra/bladder Average Price:$148.54 Average Price Allowed
By Medicare:
$15.22
HCPCS Code:99203 Description:Office/outpatient visit new Average Price:$191.00 Average Price Allowed
By Medicare:
$70.27
HCPCS Code:99221 Description:Initial hospital care Average Price:$213.00 Average Price Allowed
By Medicare:
$92.56
HCPCS Code:74430 Description:Contrast x-ray bladder Average Price:$121.00 Average Price Allowed
By Medicare:
$14.58
HCPCS Code:99214 Description:Office/outpatient visit est Average Price:$170.00 Average Price Allowed
By Medicare:
$71.96
HCPCS Code:99213 Description:Office/outpatient visit est Average Price:$117.00 Average Price Allowed
By Medicare:
$46.86
HCPCS Code:99212 Description:Office/outpatient visit est Average Price:$92.00 Average Price Allowed
By Medicare:
$23.68

HCPCS Code Definitions

52000
Cystourethroscopy (separate procedure)
51798
Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging
51797
Voiding pressure studies, intra-abdominal (ie, rectal, gastric, intraperitoneal) (List separately in addition to code for primary procedure)
51701
Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)
51700
Bladder irrigation, simple, lavage and/or instillation
51600
Injection procedure for cystography or voiding urethrocystography
51784
Electromyography studies (EMG) of anal or urethral sphincter, other than needle, any technique
51741
Complex uroflowmetry (eg, calibrated electronic equipment)
51705
Change of cystostomy tube; simple
51702
Insertion of temporary indwelling bladder catheter; simple (eg, Foley)
51729
Complex cystometrogram (ie, calibrated electronic equipment); with voiding pressure studies (ie, bladder voiding pressure) and urethral pressure profile studies (ie, urethral closure pressure profile), any technique
51715
Endoscopic injection of implant material into the submucosal tissues of the urethra and/or bladder neck
74430
Cystography, minimum of 3 views, radiological supervision and interpretation
57288
Sling operation for stress incontinence (eg, fascia or synthetic)
57160
Fitting and insertion of pessary or other intravaginal support device
52332
Cystourethroscopy, with insertion of indwelling ureteral stent (eg, Gibbons or double-J type)
99204
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-to-face with the patient and/or family.
99203
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A detailed history; A detailed examination; Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate severity. Typically, 30 minutes are spent face-to-face with the patient and/or family.
99221
Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of low severity. Typically, 30 minutes are spent at the bedside and on the patient's hospital floor or unit.
74455
Urethrocystography, voiding, radiological supervision and interpretation
99212
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family.
99214
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.
99213
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1982630174
Internal Medicine
1,391
1710976592
Pulmonary Disease
1,216
1336328202
Internal Medicine
995
1043247745
Internal Medicine
901
1629076120
Internal Medicine
895
1568471993
Internal Medicine
746
1568441251
Internal Medicine
697
1760478465
Gastroenterology
668
1902898992
Emergency Medicine
600
1174590848
Internal Medicine
583
*These referrals represent the top 10 that Dr. Gomelsky has made to other doctors

Publications

Comparison of retropubic synthetic mid-urethral slings to fascia pubovaginal slings following failed sling surgery. - Neurourology and urodynamics
Mid-urethral slings are considered first-line surgical treatment of stress urinary incontinence. However, there is a paucity of data regarding the use of mid-urethral slings (MUS) for patients who have failed a prior sling procedure.After receiving IRB approval, a multi-institutional retrospective review of 224 consecutive patients undergoing placement of a retropubic MUS (n = 153) or autologous rectus fascia (ARF) pubovaginal sling (n = 71) for prior failed sling surgery is conducted. Pre- and post-operative pad use is recorded for all patients in addition to completion of four validated questionnaires pre- and post-operatively: SEAPI-QMM incontinence classification system (stress-related leak, emptying ability, anatomy, protection, inhibition, quality of life, mobility, and mental status), incontinence impact questionnaire (IIQ-7), urogenital distress inventory (UDI-6), and 10-point visual analog score (VAS).Median follow-up is 29 months and the overall subjective cure rate was 61.4%. A statistically significant improvement in pad use and in all validated questionnaire outcomes is observed for secondary repair with a retropubic sling. In further sub-analysis between the MUS and the ARF groups, there are no significant differences in subjective cure rates or changes in post-operative questionnaire outcomes.Secondary repair with a retropubic sling is a durable and effective procedure for patients who have failed prior sling procedures without differences in outcomes noted between retropubic MUS and ARF slings. Neurourol. Urodynam. 9999:1-4, 2015. © 2015 Wiley Periodicals, Inc.© 2015 Wiley Periodicals, Inc.
Contemporary comparison between retropubic midurethral sling and autologous pubovaginal sling for stress urinary incontinence after the FDA advisory notification. - Urology
To compare the efficacy and safety in a contemporary cohort of women who were offered either a pubovaginal sling (PVS) or a synthetic midurethral sling (MUS) after the U.S. Food and Drug Administration notification and made an informed decision on procedure option.A total of 201 women were given the option between a PVS and an MUS. Prior anti-incontinence surgery and concomitant surgery other than hysterectomy were not allowed. Minimal follow-up was 12 months. Patients were prospectively followed with validated quality of life questionnaires. Cure, voiding complaints, and complications were compared between the groups.Ninety-one women (45%) underwent PVS and 110 underwent MUS (55%). Median follow-up was 13.8 months. There was no difference in baseline characteristics between the groups except for the prevalence of urge incontinence. Subjective improvement in questionnaire scores was significant for both groups. Cure rate was accomplished in 75.8% of the PVS group patients compared with 80.9% of the MUS group patients (hazard ratio, 1.35; 95% confidence interval, 0.69-2.7; P = .38). Complications and voiding difficulty were similar between the groups.In this contemporary cohort of women considered suitable candidates for either a PVS or an MUS, both offer comparable efficacy and complication rates. PVS may be safely offered to patients who would otherwise be good candidates for MUS if they are concerned with the implantation of mesh.Copyright © 2015 Elsevier Inc. All rights reserved.
The 7-year outcome of the tension-free vaginal tape procedure for treating female stress urinary incontinence. - BJU international
To evaluate the long-term results and predictive risk factors for efficacy after the tension-free vaginal tape (TVT) procedure for treating female stress urinary incontinence (SUI).Inall, 306 women (mean age 50.7 years, sd 8.7) who had a TVT procedure for SUI were selected and followed >or=7 years (mean 92.3 months, range 84-110) after surgery. We analysed the long-term results, the variables predictive of cure rates, and patient satisfaction.The overall 7-year cure rate was 84.6%, with a satisfaction rate of 69.3%. The cure rates were lower in patients with high-grade SUI (50% in grade III, 82.8% in grade II and 90.7% in grade I; P < 0.001). On multivariate analysis, there were no independent risk factors related to cure rate, and urgency was the only factor independently associated with patient satisfaction (P = 0.008; odds ratio 2.47). Seventy-one patients (23.2%) had complications at the 1-month follow-up after surgery, but only eight (2.6%) had complications at the 7-year follow-up, including mesh exposure in six and de novo urgency in two.The absence of long-term adverse events associated with the TVT procedure, and high subjective and objective 7-year success rates with no independent predictive factors affecting the long-term cure rate, make the TVT procedure a recommendable surgical treatment for female SUI.
Bladder neck pubovaginal slings. - Expert review of medical devices
Over the past 30 years, the pubovaginal sling has surpassed retropubic and transvaginal suspensions as the most common surgical operation for correcting stress urinary incontinence. This resurgence has been due in part to innovative technological advances that have shortened operative times and expedited postoperative recovery. The introduction of novel allografts, xenografts and synthetic materials has also been accompanied by unique complications, previously not encountered with autologous materials. The aim of this review is to compare the available sling materials in the context of biocompatibility and efficacy.

Map & Directions

1501 Kings Hwy Department Of Urology Shreveport, LA 71103
View Directions In Google Maps

Nearby Doctors

2600 Greenwood Rd
Shreveport, LA 71103
318 124-4500
2600 Greenwood Rd
Shreveport, LA 71103
318 124-4550
1501 Kings Hwy Department Of Ophthalmology
Shreveport, LA 71103
318 757-7737
1501 Kings Hwy Department Of Neurology
Shreveport, LA 71103
318 755-5000
1501 Kings Hwy
Shreveport, LA 71103
318 755-5000
1501 Kings Hwy Department Of Pediatrics, Section Of Neonatology
Shreveport, LA 71103
318 757-7255
1501 Kings Hwy Department Of Psychiatry
Shreveport, LA 71103
318 132-2445
1501 Kings Hwy Department Of Neurology
Shreveport, LA 71103
318 132-2482
1501 Kings Hwy Department Of Otolaryngology
Shreveport, LA 71103
318 757-7737